If you are wondering whether AstraZeneca's share price still offers value or is starting to look expensive, the next sections will walk through what the current market price might be implying.

Increase of 6.4% comes as drugmaker reports strong profit growth, despite cancelling UK investment projects ...

Pascal Soriot suggests UK-US agreement will not be enough to revive plan to expand Cambridge site ...

AstraZeneca stock rose 230p (1.64 per cent) to 14,118 per share within an hour of the London stockmarket opening this morning with AZ basking in the heat of a near-£216 billion market cap.

AstraZeneca received FDA approval for Calquence with venetoclax, creating the first all oral, fixed duration regimen for adults with chronic lymphocytic leukemia and small lymphocytic lymphoma. The ...

On CNBC's “Halftime Report Final Trades,” Joshua Brown, co-founder and CEO of Ritholtz Wealth Management, said he remains ...